We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ADBE:NASDAQAdobe Inc. Analysis

Data as of 2026-08-29 - not real-time

$291.52

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Adobe Inc. is priced at $291.52, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has gained 22.9%. Relative strength is 68.8 — approaching overbought — and the MACD signal is bullish. The recent range runs from support at $245.46 up to resistance at $294.09.
On valuation the read is fair — earnings multiple of 16.5 versus a 35.7 sector average, below the peer group. Sell-side targets cluster 7.2% below the current quote. Revenue is growing at 12.7% on a 28.7% profit margin.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 51.9%, a beta of 0.31 and a maximum drawdown of 47.4%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Daniel Sparks, The Motley Fool Aug 16, 2026 1 Key Points - Adobe shares trade at about 10 times the earnings analysts...Adobe Systems ADBE closed the most recent trading day at $275.Adobe has lost nearly a quarter of its value over the past year while posting record revenue and tripling its AI...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 269.18
  • MACD momentum is positive
  • 30-day price change of +22.9%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 16.5 versus sector average of 35.7
  • Trading above the 200-day average of 269.18
  • Analyst targets imply -7.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 16.5 versus sector average of 35.7
  • Analyst targets imply -7.2% versus the current price
  • Profit margin of 28.7% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth12.70%
Profit Margin28.69%
P/E Ratio16.5
ROE62.95%
ROA19.93%
Debt/Equity61.44
P/B Ratio10.1
Op. Cash Flow$10.5B
Free Cash Flow$9.2B
Industry P/E35.7

Technical Analysis

TrendNeutral
RSI68.8
Support$245.46
Resistance$294.09
MA 20$268.25
MA 50$240.18
MA 200$269.18
MACDBullish
VolumeStable
Fear & Greed Index95.66

Valuation

Fair Value$502.21
Target Price$270.61
Upside/Downside-7.17%
GradeFair
TypeGrowth

Risk Assessment

Beta0.31
Volatility51.92%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.